Redesign Science
Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
7
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
38
organic / mo
Sign up free to see all 6 verified contacts at Redesign Science
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- DR
David Rooklin
Cofounder, CEO · Other
EmailPhone
Showing 1 of 6 verified contacts
Top roles at Redesign Science
4 distinct titles indexed · top 4 shown.
- 1()
- 1cofounder, ceo
- 1machine learning intern
- 1principal scientist, computational chemistry
Sign up to unlock all 6 contacts at Redesign Science
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Redesign Science
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.